Event Overview
On July 2, the China Securities Regulatory Commission (CSRC) approved the registration application of Unitree Robotics (宇树科技) for an initial public offering and listing on the STAR Market (科创板). The approval is valid for 12 months from the date of registration — meaning that within one year at most, this Chinese quadruped/humanoid robotics company founded in 2016 will enter mainstream investors'视野 via the public market.
According to disclosed prospectus data: founder Wang Xingxing, born in 1990, established Unitree in Hangzhou in 2016. The company's core business is civilian quadruped robots and humanoid robots, and it leads globally in quadruped robot sales. As of June 2025, total headcount exceeded 1,000 employees.
The most notable point is the "full-stack self-development" of the supply chain. Unitree has achieved fully domestic, in-house development of core components — joint motors, reducers, and controllers — meaning a joint unit costs only about one-third of imported products. For a hardware company, this cost structure is both the foundation of pricing power and the key to withstanding supply-chain geopolitical risk.
Deep Analysis
First, this is the first milestone of "Chinese embodied intelligence" moving from the private financing era to public markets.
Over the past few years, domestic embodied intelligence companies have raised funds mainly in private markets — Unitree itself raised multiple rounds. But private-market valuations circulate only among institutional LPs, with poor liquidity, opaque pricing, and weak resilience across cycles. An IPO is the event that truly hands pricing power and oversight to the public market. Once Unitree lists successfully, it means Chinese embodied intelligence has its first "public yardstick": investors can evaluate the intrinsic value of embodied intelligence companies using the same financial models, short-selling mechanisms, and broker research systems.
Second, the STAR Market's tolerance for "hard tech + sustained losses" is the practical basis for Unitree's chosen path.
Embodied intelligence companies generally sit in a state of "high R&D investment, unprofitable, unstable orders" — vastly different from traditional manufacturing financial models. The STAR Market's fifth listing standard (allowing unprofitable companies to list) and its hard requirements on R&D spending ratio are tailor-made for such companies. Unitree obtaining approval is, to some degree, also a regulatory endorsement that "embodied intelligence is a national-level hard-tech direction."
Third, "full-stack self-developed core components + one-third the cost" carries strategic significance — in the geopolitical context — far greater than its commercial significance.
Joint motors, reducers, and controllers are a robot's "muscles," traditionally monopolized by Japan's Harmonic Drive, the US's Moog, and others. If export controls tighten (as with 2022 restrictions on Category A robot exports), China's embodied intelligence industry would immediately face a chokepoint. Unitree domesticating these components at one-third the cost is essentially a "decoupling insurance policy" at the supply-chain level.
Fourth, founder Wang Xingxing's personal shareholding ratio in the ownership structure deserves attention.
The founder's personal stake reflects governance stability and long-term vision. In embodied intelligence — a track with 5–10 year product cycles — the founder's control directly determines R&D cadence. Wang's technical background (robot mechanical structures, control systems, hardware engineering) is a scarce profile among domestic peers; tech-founder-led embodied intelligence companies are rare even globally.
Why It Matters
Unitree's IPO approval is the first complete closed loop for "Chinese embodied intelligence" — from concept to engineering to public-market validation. It sends at least three signals to the industry:
- Chinese regulators have identified embodied intelligence as a strategic-level tech direction and are willing to back it with the strictest capital market (STAR Market registration-based IPO system)
- Investors finally have a publicly comparable embodied intelligence company for due diligence; pricing of subsequent companies will become more transparent
- Full-stack self-development of upstream core components has been proven as a "listable" business model; domestic substitution on the supply side will accelerate
Risks and Watchpoints
First, "fifth-standard listing + IPO registration approval" does not mean an immediate listing — roadshows, pricing, subscriptions, and other steps remain. The 12-month approval validity is a "window," not a "promise"; the final bell-ringing is still subject to variables.
Second, the "commercialization inflection point" for embodied intelligence has yet to arrive. Unitree leads globally in quadruped robot sales, but quadruped applications are mainly performance, education, and research — not must-have consumer goods. Humanoid robots are still at the PoC stage. How a company whose main business is "hardware + algorithms" explains "three-year growth prospects" in its prospectus will determine what P/E the market is willing to assign.
Third, even if the IPO succeeds, the valuation model for embodied intelligence remains immature — traditional manufacturing uses P/E, software uses P/S; no global consensus exists on what multiple to use for embodied intelligence. Unitree's listing will, to some extent, "force" primary and secondary markets to jointly develop a new valuation framework.
Source: CSRC July 2 announcement, IT之家 compilation, Unitree Robotics prospectus disclosures.